Salesforce (CRM) Stock Forecast & Price Target

$151.67 -0.11 (-0.07%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$152.28 +0.61 (+0.40%)

As of 06/18/2026 07:59 PM Eastern

Compare

Salesforce - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 42 Analyst Ratings

Sell
4

Hold
11

Buy
27

Based on 42 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 42 analysts, 4 have given a sell rating, 11 have given a hold rating, 26 have given a buy rating, and 1 has given a strong buy rating for CRM.

Consensus Price Target

$257.61
69.85% Upside

According to the 42 analysts' twelve-month price targets for Salesforce, the average price target is $257.61. The highest price target for CRM is $400.00, while the lowest price target for CRM is $160.00. The average price target represents a forecasted upside of 69.85% from the current price of $151.67.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRM Analyst Ratings Over Time

Type	Current Forecast 6/20/25 to 6/20/26	1 Month Ago 5/21/25 to 5/21/26	3 Months Ago 3/22/25 to 3/22/26	1 Year Ago 6/20/24 to 6/20/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	3 Strong Buy rating(s)
Buy	26 Buy rating(s)	25 Buy rating(s)	26 Buy rating(s)	28 Buy rating(s)
Hold	11 Hold rating(s)	10 Hold rating(s)	11 Hold rating(s)	8 Hold rating(s)
Sell	4 Sell rating(s)	3 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$257.61	$274.56	$280.21	$349.08
Forecasted Upside	69.85% Upside	55.69% Upside	43.59% Upside	33.86% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	Broader Market
Consensus Rating Score	2.57	2.29	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	69.85% Upside	157.89% Upside	15.89% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
6/18/2026	Barclays 3 of 5 stars	Raimo Lenschow 2 of 5 stars	Upgrade	Overweight
6/18/2026	Scotiabank 4 of 5 stars		Downgrade	Sector Outperform ➝ Sector Perform
6/18/2026	HC Wainwright 4 of 5 stars		Downgrade	Negative
6/18/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy ➝ Neutral
6/18/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$200.00	+29.13%
6/17/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C-) ➝ Sell (D+)
6/16/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
6/16/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
6/16/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$225.00	+38.43%
6/15/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
Forget the million-dollar nest egg (Ad) Nearly 2 in 3 Americans fear running out of money more than death - and chasing a $1.5 million nest egg isn't helping. Tim Plaehn has spent decades helping people build retirement income, and he says the monthly income goal is the only number that matters. His approach could potentially reach that goal with 10x less capital - using a single stock you can buy with one click. Watch the short presentation to see how this retirement income strategy works
6/15/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
6/12/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
6/4/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral
6/2/2026	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$295.00 ➝ $280.00	+53.24%
5/29/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$350.00 ➝ $356.00	+86.39%
5/28/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
5/28/2026	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$325.00	+82.72%
5/28/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$300.00 ➝ $290.00	+63.05%
5/28/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform
5/28/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Underperform	$194.00 ➝ $173.00	-3.50%
5/28/2026	Macquarie Infrastructure Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Koenig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$200.00 ➝ $190.00	+5.84%
5/28/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform	$315.00	+75.38%
5/28/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$210.00 ➝ $200.00	+11.36%
5/28/2026	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$205.00 ➝ $240.00	+33.36%
5/28/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$250.00	+38.92%
5/28/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$200.00 ➝ $175.00	-2.76%
5/28/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$225.00 ➝ $215.00	+21.11%
5/28/2026	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$325.00	+82.72%
5/26/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$255.00	+41.41%
5/18/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tal Liani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy ➝ Underperform	$160.00	-7.93%
3/10/2026	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nehal Chokshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Market Perform	$267.00 ➝ $229.00	+15.24%
2/26/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry Tillman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$280.00	+40.45%
2/26/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$275.00 ➝ $250.00	+30.08%
2/26/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$365.00 ➝ $320.00	+60.50%
2/26/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$280.00 ➝ $265.00	+33.78%
2/26/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$300.00 ➝ $250.00	+27.84%
2/23/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$398.00 ➝ $287.00	+55.05%
12/11/2025	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
12/4/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$340.00 ➝ $360.00	+49.91%
12/4/2025	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kirk Materne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$360.00 ➝ $340.00	+42.58%
PH: Do THESE 4 things to your bank account now … (Ad) In a few short months, the US government could gain unprecedented powers over personal bank accounts - including the ability to track every transaction or freeze funds. Martin D. Weiss, PhD, founder of Weiss Ratings, has identified 4 simple steps Americans can take today to help safeguard their savings before any changes take effect. Discover all 4 steps to help protect your bank account now
12/4/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$325.00 ➝ $315.00	+32.09%
12/4/2025	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
6/5/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold
5/30/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$311.00 ➝ $309.00	+16.88%
5/28/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$320.00	+15.55%
2/27/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$330.00 ➝ $300.00	+0.80%
2/19/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omar Sheikh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy
10/17/2024	Cfra Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$343.00	+16.88%
8/30/2024	Phillip Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy ➝ Accumulate	$305.00	+20.72%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shebly Seyrafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stefan Slowinski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Strong-Buy	$325.00 ➝ $350.00	+35.19%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:40 PM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, June 19, 2026. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

The company recently reported strong quarterly earnings, with earnings per share significantly exceeding analysts' expectations, indicating robust financial performance.
Salesforce, Inc. has a substantial market capitalization, reflecting its strong position in the cloud-based software market, which is expected to continue growing.
The current stock price is around $177, which may be considered attractive given the company's growth potential and recent performance.
Salesforce, Inc. has initiated a significant share repurchase program, indicating that the board believes the stock is undervalued, which can enhance shareholder value.
The company has a solid dividend payout ratio, providing a steady income stream for investors, which is appealing in a volatile market.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

The company has a relatively high debt-to-equity ratio, which may indicate increased financial risk if market conditions change.
Salesforce, Inc. has a current ratio below 1, suggesting potential liquidity issues that could affect its ability to meet short-term obligations.
Despite recent growth, the company's stock price has shown volatility, which may deter risk-averse investors.
The P/E ratio is moderate, which could suggest that the stock is fairly valued, limiting potential upside for investors looking for significant gains.
Analysts predict a modest earnings growth rate for the current fiscal year, which may not meet the expectations of aggressive growth investors.

CRM Forecast - Frequently Asked Questions

According to the research reports of 42 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $257.61, with a high forecast of $400.00 and a low forecast of $160.00.

42 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last twelve months. There are currently 4 sell ratings, 11 hold ratings, 26 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRM shares.

According to analysts, Salesforce's stock has a predicted upside of 69.85% based on their 12-month stock forecasts.

Over the previous 90 days, Salesforce's stock had 5 downgrades and 3 upgrades by analysts.

Salesforce has been rated by research analysts at B. Riley Financial, Bank of America, Barclays, BMO Capital Markets, BTIG Research, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, Citizens Jmp, DA Davidson, Daiwa Securities Group, HC Wainwright, HSBC, Jefferies Financial Group, KeyCorp, Macquarie Infrastructure, Monness Crespi & Hardt, Needham & Company LLC, Piper Sandler, Roth Mkm, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, TD Cowen, The Goldman Sachs Group, UBS Group, Wedbush, Weiss Ratings, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Salesforce more than other "computer and technology" companies. The consensus rating for Salesforce is Moderate Buy while the average consensus rating for "computer and technology" companies is Hold. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Salesforce Recommendations

This page (NYSE:CRM) was last updated on 6/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target